tradingkey.logo

Viatris Inc

VTRS
10.490USD
-0.040-0.38%
收盤 11/04, 16:00美東報價延遲15分鐘
12.23B總市值
虧損本益比TTM

Viatris Inc

10.490
-0.040-0.38%

關於 Viatris Inc 公司

Viatris Inc. 是一家全球醫療保健公司。該公司的部門包括髮達市場、大中華區、JANZ 和新興市場。發達市場部門主要包括其在北美和歐洲的業務。大中華區部門包括其在中國、臺灣和香港的業務。JANZ 部門反映其在日本、澳大利亞和新西蘭的業務。新興市場部門涵蓋其在 125 多個國家/地區的發展中市場和新興經濟體的業務,包括亞洲、非洲、東歐、拉丁美洲和中東,以及該公司的 ARV 特許經營權。該公司的產品組合包括一系列關鍵治療領域的已獲批准分子,包括全球公認的標誌性和關鍵品牌和仿製藥,包括複雜產品。該公司在全球設有生產基地,生產口服固體劑、注射劑和複雜劑型。

Viatris Inc簡介

公司代碼VTRS
公司名稱Viatris Inc
上市日期Feb 01, 1973
CEOMr. Scott A. Smith
員工數量32000
證券類型Ordinary Share
年結日Feb 01
公司地址1000 Mylan Boulevard
城市CANONSBURG
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編15317
電話17245141465
網址https://www.viatris.com/en
公司代碼VTRS
上市日期Feb 01, 1973
CEOMr. Scott A. Smith

Viatris Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Ms. Theodora (Doretta) Mistras
Ms. Theodora (Doretta) Mistras
Chief Financial Officer
Chief Financial Officer
25.18K
--
Ms. JoEllen Lyons Dillon
Ms. JoEllen Lyons Dillon
Independent Director
Independent Director
--
--
Mr. Mark W. Parrish
Mr. Mark W. Parrish
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Melina E. Higgins
Ms. Melina E. Higgins
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Brands
2.28B
64.01%
Generics
1.28B
35.99%
地區USD
名稱
營收
佔比
Developed markets
2.12B
59.38%
Greater China
588.90M
16.50%
Emerging Markets
555.10M
15.55%
JANZ
305.70M
8.57%
業務
地區
業務USD
名稱
營收
佔比
Brands
2.28B
64.01%
Generics
1.28B
35.99%

股東統計

更新時間: 11月4日 週二
更新時間: 11月4日 週二
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.51%
T. Rowe Price Associates, Inc.
6.65%
Davis Selected Advisers, L.P.
5.74%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.78%
其他
65.01%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.51%
T. Rowe Price Associates, Inc.
6.65%
Davis Selected Advisers, L.P.
5.74%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.78%
其他
65.01%
股東類型
持股股東
佔比
Investment Advisor
43.82%
Investment Advisor/Hedge Fund
27.30%
Hedge Fund
8.39%
Research Firm
2.42%
Pension Fund
1.45%
Sovereign Wealth Fund
1.00%
Bank and Trust
0.98%
Individual Investor
0.27%
Family Office
0.06%
其他
14.30%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1934
987.12M
85.35%
-46.41M
2025Q2
1947
984.91M
83.97%
-87.31M
2025Q1
2006
1.01B
85.93%
-61.76M
2024Q4
2002
1.03B
86.53%
+1.20M
2024Q3
1949
989.28M
82.89%
-66.19M
2024Q2
1967
1.02B
85.33%
-16.59M
2024Q1
1986
997.86M
84.00%
-35.39M
2023Q4
2032
990.53M
82.57%
-31.15M
2023Q3
2044
970.48M
80.90%
-45.34M
2023Q2
2080
963.51M
80.35%
-35.04M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
144.70M
12.41%
+694.66K
+0.48%
Jun 30, 2025
T. Rowe Price Associates, Inc.
76.96M
6.6%
+4.28M
+5.89%
Jun 30, 2025
Davis Selected Advisers, L.P.
66.38M
5.69%
+1.43M
+2.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
61.38M
5.26%
-2.94M
-4.57%
Jun 30, 2025
State Street Investment Management (US)
55.29M
4.74%
-6.17M
-10.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
31.26M
2.68%
+10.00M
+47.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
31.23M
2.68%
+52.78K
+0.17%
Jun 30, 2025
Invesco Capital Management LLC
24.15M
2.07%
+928.68K
+4.00%
Jun 30, 2025
Deerfield Management Company, L.P.
24.02M
2.06%
+32.31K
+0.13%
Jun 30, 2025
Columbia Threadneedle Investments (US)
22.77M
1.95%
+1.16M
+5.38%
Jun 30, 2025
查看更多

持股ETF

更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
iShares U.S. Pharmaceuticals ETF
5.01%
First Trust NASDAQ Pharmaceuticals ETF
4.3%
SPDR S&P Pharmaceuticals ETF
3.86%
Davis Select US Equity ETF
3.12%
Invesco Pharmaceuticals ETF
2.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.81%
Leatherback Long/Short Alternative Yield ETF
2.74%
Invesco S&P Ultra Dividend Revenue ETF
2.64%
Alps Sector Dividend Dogs ETF
2.23%
Pacer US Small Cap Cash Cows ETF
2.16%
查看更多
iShares U.S. Pharmaceuticals ETF
佔比5.01%
First Trust NASDAQ Pharmaceuticals ETF
佔比4.3%
SPDR S&P Pharmaceuticals ETF
佔比3.86%
Davis Select US Equity ETF
佔比3.12%
Invesco Pharmaceuticals ETF
佔比2.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比2.81%
Leatherback Long/Short Alternative Yield ETF
佔比2.74%
Invesco S&P Ultra Dividend Revenue ETF
佔比2.64%
Alps Sector Dividend Dogs ETF
佔比2.23%
Pacer US Small Cap Cash Cows ETF
佔比2.16%

分紅派息

近5年累計派現 2.13B 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 27, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 18, 2025
Mar 10, 2025
Nov 05, 2024
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 13, 2024 going ex on Nov 22, 2024
Nov 22, 2024
Dec 13, 2024
Nov 22, 2024
Aug 06, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 13, 2024 going ex on Aug 23, 2024
Aug 23, 2024
Sep 13, 2024
Aug 23, 2024
May 09, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 14, 2024 going ex on May 23, 2024
May 24, 2024
Jun 14, 2024
May 23, 2024
Feb 28, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2024 going ex on Mar 08, 2024
Mar 11, 2024
Mar 18, 2024
Mar 08, 2024
Nov 08, 2023
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2023 going ex on Nov 22, 2023
Nov 24, 2023
Dec 15, 2023
Nov 22, 2023
Aug 07, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2023 going ex on Aug 23, 2023
Aug 24, 2023
Sep 15, 2023
Aug 23, 2023
May 08, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 16, 2023 going ex on May 23, 2023
May 24, 2023
Jun 16, 2023
May 23, 2023
Feb 27, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 17, 2023 going ex on Mar 08, 2023
Mar 09, 2023
Mar 17, 2023
Mar 08, 2023
Nov 08, 2022
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 16, 2022 going ex on Nov 22, 2022
Nov 23, 2022
Dec 16, 2022
Nov 22, 2022
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI